Shelo NABEL D B T Cream
- Manufacturer
- Corporativo Serysi S de R L de C V
- Effective date
- 2019-10-15
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-05-31 23:00:50
Label at a glance#
ProductShelo NABEL D B T Cream
Active ingredientALLANTOIN
Label structure8 sections
Label contents#
Full prescribing information#
Inactive Ingredient U145
Warnings U145
Purpose U145
KOROC
Administration U145
Indcations U145
Display Panel
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71424-1145-1 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-5bc8-a910-e053-dadaa90a0b85 | Sheló NABEL D-B-T Cream |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71424-1145-1 | Shelo NABEL D B T Cream | 280 g in 1 BOTTLE, DISPENSING | CREAM | 280 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71424-1145 | SHELO NABEL D B T CREAM (ALLANTOIN) CREAM [CORPORATIVO SERYSI S DE R L DE C V] | 5 | Legacy NDC, 1 package rows | 20191016_50133516-349c-1e57-e054-00144ff8d46c.zip |
Products#
Every source-derived product name is available through these pages.
- Shelo NABEL D B T Cream
- Allantoin
- ISOPROPYL PALMITATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 71424-1145 | 71424-1145-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALLANTOIN | 344S277G0Z | ACTIB |
| ISOPROPYL PALMITATE | 8CRQ2TH63M | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 94fa7dd2-c3fa-27ac-e053-2a95a90a93b3 | 50133516-349c-1e57-e054-00144ff8d46c | 2019-10-15 | Warnings | 94fa7dd2-c3fa-27ac-e053-2a95a90a93b3 50133516-349c-1e57-e054-00144ff8d46c |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.







